title: Antimicrobial susceptibility of pneumococcal isolates causing bacteraemic pneumococcal pneumonia: analysis using current breakpoints and fluoroquinolone pharmacodynamics.
authors.forename: C
authors.initials: C
authors.lastname: Feldman
authors.forename: A J
authors.initials: AJ
authors.lastname: Brink
authors.forename: A
authors.initials: A
authors.lastname: von Gottberg
authors.forename: N
authors.initials: N
authors.lastname: Wolter
authors.forename: L
authors.initials: L
authors.lastname: de Gouveia
authors.forename: O
authors.initials: O
authors.lastname: Perovic
authors.forename: K P
authors.initials: KP
authors.lastname: Klugman
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000493:pharmacokinetics / Q000494:pharmacology*; D016470:Bacteremia / Q000382:microbiology*; D017714:Community-Acquired Infections / Q000382:microbiology; D024881:Drug Resistance, Bacterial; D024841:Fluoroquinolones / Q000493:pharmacokinetics / Q000494:pharmacology*; D006801:Humans; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D011018:Pneumonia, Pneumococcal / Q000150:complications* / Q000382:microbiology*; D013296:Streptococcus pneumoniae / Q000187:drug effects* / Q000302:isolation & purification
chemical_list: D000900:Anti-Bacterial Agents; D024841:Fluoroquinolones